A carregar...
Beyond The Needle: Biotech’s Delivery Challenge
Finding new ways to administer biologics could lead to higher patient acceptance and lower costs, and prove crucial as biotech companies release products aimed at more prevalent diseases. Here’s a look at the emerging world of noninjectable biologics.
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioCommunications LLC
2004
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564283/ https://ncbi.nlm.nih.gov/pubmed/23390391 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|